Podcasts

Podcasts | Feb. 27, 2014

Ask the Expert - Cardiac Issues and Lupus

This month's Ask the Experts features Jim Oates, MD, and Monica Richey, MSN, ANP-bc/GNP in a two-part presentations on cardiac issues and lupus. Listen to their presentations now!

Podcasts | Feb. 12, 2014

Hydroxycloroquine May Help Prevent APS Pregnancy Complications

Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.

Podcasts | Jan. 03, 2014

Ask the Experts: Health Insurance Marketplace

Ask the Experts: Susan Gustafson, Health Insurance Specialist, Centers for Medicare & Medicaid Services discusses the Health Insurance Marketplace

Podcasts | Nov. 13, 2013

Biomarkers of Lupus Disease: Eliminating the Perplexities of Lupus Treatment Trials

Lupus Foundation of America medical director Dr. Joan Merrill discusses a recently completed a study that may help to improve the design for future lupus clinical trials and secure approval of new safe and more tolerable treatments for lupus.

Podcasts | Nov. 12, 2013

App Assists Transition from Pediatric to Adult Lupus Care

Dr. Miriam Kaufman discusses a smartphone app that helps adolescents make the transition from pediatric to adult lupus care.

Podcasts | Nov. 08, 2013

Pediatric Lupus Health-Related Quality of Life Research

Dr. Hermine Brunner of the Cincinnati Children's Hospital discusses her research on health-related quality of life in children and adolescents with lupus.

Podcasts | Nov. 07, 2013

Human Mesenchymal Stem Cells as a Potential Therapy for Lupus

Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.

Podcasts | Nov. 05, 2013

New Research Gives Insight for Improving Future Lupus Clinical Trials

Dr. Kenneth Kalunian discusses the Lupus Foundation of America Collective Data Analysis Initiative (LFA CDAI) which is providing insight into the impact various background medications may have on lupus clinical trial outcomes.